ReviewJournal of cellular and molecular medicine2021

Mixed responses to first-line alectinib in non-small cell lung cancer patients with rare ALK gene fusions: A case series and literature review.

Mengnan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.